Exact Sciences (NASDAQ:EXAS) just reported results for the first quarter of 2024.
- Exact Sciences reported earnings per share of -60 cents. This was below the analyst estimate for EPS of -46 cents.
- The company reported revenue of $637.52 million.
- This was 1.65% better than the analyst estimate for revenue of $627.17 million.